NIMG-17. UTILIZING MACHINE LEARNING FOR PREDICTIVE MODELING OF SEIZURE PRESENTATION IN GLIOMA PATIENTS. (5th November 2018)
- Record Type:
- Journal Article
- Title:
- NIMG-17. UTILIZING MACHINE LEARNING FOR PREDICTIVE MODELING OF SEIZURE PRESENTATION IN GLIOMA PATIENTS. (5th November 2018)
- Main Title:
- NIMG-17. UTILIZING MACHINE LEARNING FOR PREDICTIVE MODELING OF SEIZURE PRESENTATION IN GLIOMA PATIENTS
- Authors:
- Khurana, Aditya
Ranjbar, Sara
Johnston, Sandra
Hu, Leland
Whitmire, Paula
Sharma, Akanksha
Swanson, Kristin - Abstract:
- Abstract: PURPOSE: Seizures are frequent symptoms of gliomas. Predicting which patients are more likely to seize and in turn require anti-epileptic management has been a challenge. Correctly identifying these patients could help optimize care and minimize side effects. To provide guidance for clinicians, we used machine learning techniques to predict seizure presentation in this population. METHODS: We used volumetric data of pre-treatment MR images (T1Gd and T2-FLAIR sequences), patient demographics (age; sex), and measurements of tumor proliferation (log()), invasiveness (log(D)) and their relative ratio (log(/D)). We compared the performance of 5 machine learning models in predicting seizure status, using Artificial Neural Network, Naive Bayes (NB), Linear Discriminant Analysis (LDA), Random Forest, and Support Vector Machine. Correlations between probability of seizure presentation ( p (SP)) and continuous variables were also analyzed. RESULTS: Our cohort consisted of 59 seizure-presenting and 77 non-seizure-presenting patients. All models consistently demonstrated significant correlations (p < 0.05) between ( p (SP)) and the following variables: T1Gd radius (-0.781 to -0.674), T2-FLAIR (-0.674 to -0.611), and log(/D) (0.169 to 0.294). Age was significant (p < 0.05) in 4 of the 5 models (-0.211 to -0.175). Mean performance measures for the models (and the best performer) were: 0.726 for Area under the ROC curve (0.75 with NB), 0.6202 for sensitivity (0.661 with NB), 0.74Abstract: PURPOSE: Seizures are frequent symptoms of gliomas. Predicting which patients are more likely to seize and in turn require anti-epileptic management has been a challenge. Correctly identifying these patients could help optimize care and minimize side effects. To provide guidance for clinicians, we used machine learning techniques to predict seizure presentation in this population. METHODS: We used volumetric data of pre-treatment MR images (T1Gd and T2-FLAIR sequences), patient demographics (age; sex), and measurements of tumor proliferation (log()), invasiveness (log(D)) and their relative ratio (log(/D)). We compared the performance of 5 machine learning models in predicting seizure status, using Artificial Neural Network, Naive Bayes (NB), Linear Discriminant Analysis (LDA), Random Forest, and Support Vector Machine. Correlations between probability of seizure presentation ( p (SP)) and continuous variables were also analyzed. RESULTS: Our cohort consisted of 59 seizure-presenting and 77 non-seizure-presenting patients. All models consistently demonstrated significant correlations (p < 0.05) between ( p (SP)) and the following variables: T1Gd radius (-0.781 to -0.674), T2-FLAIR (-0.674 to -0.611), and log(/D) (0.169 to 0.294). Age was significant (p < 0.05) in 4 of the 5 models (-0.211 to -0.175). Mean performance measures for the models (and the best performer) were: 0.726 for Area under the ROC curve (0.75 with NB), 0.6202 for sensitivity (0.661 with NB), 0.74 for specificity (0.766 with LDA). The 5 features ranked as most important were: T1Gd, T2-FLAIR, log(/D), age, log(). CONCLUSIONS: We found an association in seizure-presenting patients with smaller, more proliferative tumors and younger age. Machine learning predictive modeling can potentially be informative in the clinical arena. Further validation studies, to determine the degree of data overfitting, model versatility, as well as performance on test data, are warranted. … (more)
- Is Part Of:
- Neuro-oncology. Volume 20(2018)Supplement 6
- Journal:
- Neuro-oncology
- Issue:
- Volume 20(2018)Supplement 6
- Issue Display:
- Volume 20, Issue 6 (2018)
- Year:
- 2018
- Volume:
- 20
- Issue:
- 6
- Issue Sort Value:
- 2018-0020-0006-0000
- Page Start:
- vi179
- Page End:
- vi179
- Publication Date:
- 2018-11-05
- Subjects:
- Brain Neoplasms -- Periodicals
Brain -- Tumors -- Periodicals
Brain -- Cancer -- Periodicals
Nervous system -- Cancer -- Periodicals
616.99481 - Journal URLs:
- http://neuro-oncology.dukejournals.org/ ↗
http://neuro-oncology.oxfordjournals.org/ ↗
http://www.oxfordjournals.org/content?genre=journal&issn=1522-8517 ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/neuonc/noy148.744 ↗
- Languages:
- English
- ISSNs:
- 1522-8517
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.288000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12325.xml